The Biotechnology Value Fund (BVF) LP of the US and affiliates have invested €30 million via a share placement in Evotec AG and taken out an option to buy a further stake from an existing shareholder, which could raise the holding to more than 18%. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
